Infectious Disease and Microbiology – Chromobacterium violaceum

Overview

Chromobacterium violaceum is a rare environmental Gram-negative bacillus that can cause serious human infection after traumatic inoculation or exposure to contaminated water. Although infection is uncommon, it can progress rapidly from a localized wound infection to bacteremia, sepsis, pneumonia, or metastatic abscesses.

Severe disease is especially concerning in patients with chronic granulomatous disease or significant neutrophil dysfunction.

Microbiologic Characteristics

Chromobacterium violaceum is an aerobic Gram-negative bacillus.

Many strains produce a characteristic violet pigment known as violacein, which may give colonies a purple appearance in culture. However, not all strains are pigmented, so absence of violet coloration does not exclude the organism.

Epidemiology

The organism is distributed worldwide, particularly in tropical and subtropical environments.

It is found mainly in:

• Soil

• Fresh water

• Mud

• Natural water sources

Human infection is rare and usually follows environmental exposure.

Transmission

Infection most often occurs when contaminated soil or water enters through a break in the skin.

Typical routes include:

• Traumatic wounds

• Puncture injuries

• Cuts exposed to contaminated water

• Near-drowning or aspiration of contaminated water

The organism can invade locally and then spread hematogenously.

Risk Factors

Important risk factors for severe disease include:

• Chronic granulomatous disease

• Neutropenia

• Other disorders of phagocyte function

• Significant immunosuppression

Patients with chronic granulomatous disease are particularly susceptible because of impaired intracellular killing of certain catalase-positive organisms.

Clinical Infections

Traumatic Wound Infection

Localized infection may develop after environmental contamination of a wound.

Possible findings include:

• Pain

• Erythema

• Swelling

• Purulent drainage

• Cellulitis

• Abscess formation

Because progression can be rapid, patients with systemic symptoms should be assessed for bloodstream spread.

Sepsis

One of the most serious manifestations is bacteremia with sepsis.

Clinical findings may include:

• High fever

• Hypotension

• Tachycardia

• Altered mental status

• Septic shock

• Multiorgan dysfunction

Severe systemic infection is especially important in neutropenic patients and those with chronic granulomatous disease.

Metastatic Abscesses

Hematogenous dissemination may lead to abscess formation in distant organs.

Potential sites include:

• Liver

• Lung

• Spleen

• Brain

• Skin and soft tissues

Persistent fever despite therapy should raise concern for metastatic infection.

Pneumonia

Pneumonia can occur after aspiration of contaminated water, particularly following drowning or near-drowning.

Patients may develop:

• Fever

• Cough

• Dyspnea

• Hypoxemia

• Pulmonary infiltrates

A history of freshwater exposure can provide an important diagnostic clue.

Diagnosis

Diagnosis is established primarily by culture.

Appropriate specimens may include:

• Wound material

• Blood

• Respiratory secretions

• Abscess fluid

• Tissue specimens

The characteristic violet pigmentation, when present, can strongly suggest C. violaceum, but definitive identification requires microbiologic testing.

Treatment

Doxycycline

Doxycycline has activity against C. violaceum and may be useful in susceptible infections.

Fluoroquinolones

Fluoroquinolones, particularly agents such as ciprofloxacin, have historically shown good activity and may be used when susceptibility supports treatment.

Severe Infection

For serious systemic disease, treatment may include a broad-spectrum active agent such as:

• Imipenem

or historically

• A ureidopenicillin in combination with an aminoglycoside

Because antimicrobial susceptibility can vary, severe infection should be treated according to culture and susceptibility results.

Additional Treatment Options

Other agents that may have activity include:

• Trimethoprim-sulfamethoxazole

• Aminoglycosides

Therapy should be individualized based on the infection site, disease severity, and microbiology results.

Source Control

Abscesses and infected wounds may require:

• Surgical drainage

• Debridement

• Removal of devitalized tissue

Source control is especially important in patients with deep or metastatic infection.

Prevention

Prevention includes careful wound protection and avoidance of contamination with untreated freshwater or soil, particularly in high-risk patients.

Important measures include:

• Clean traumatic wounds promptly

• Cover open wounds during freshwater exposure

• Avoid swimming with significant open wounds

• Use particular caution in patients with chronic granulomatous disease

High-Yield Clinical Pattern

Freshwater or soil-contaminated wound

Rapidly progressive infection

Sepsis or metastatic abscesses

→ Think Chromobacterium violaceum

High-Yield Risk Pattern

Patient with chronic granulomatous disease

Severe Gram-negative sepsis after environmental exposure

→ Consider C. violaceum

Exam Essentials

Organism: Chromobacterium violaceum

Microbiology: Aerobic Gram-negative bacillus

Environmental reservoir: Soil and freshwater

Characteristic culture clue: Violet pigment in many strains

Major infections: Wound infection, bacteremia/sepsis, pneumonia

Important complication: Metastatic abscess formation

Major risk factor: Chronic granulomatous disease

Diagnosis: Culture

Commonly active agents: Doxycycline or fluoroquinolones

Severe infection: Carbapenem-based therapy may be appropriate

Additional agents: TMP-SMX or aminoglycosides

Key clinical pearl: A rapidly progressive infection after freshwater or soil exposure, especially in a patient with chronic granulomatous disease, should raise concern for Chromobacterium violaceum.